Tevogen Bio Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tevogen Bio Holdings generated cash of -$1,376,351, which is less than the previous year. Cash used in financing activities reached the amount of -$341,660,930 last year. Net change in cash is therefore -$120,351.
Cash Flow
| 2022 | -215.39K | -479 | 7.5K |
|---|---|---|---|
| 2023 | -1.37M | 342.91M | -341.66M |
TVGN Cash Flow Statement (2022 – 2023)
| 2023 | 2022 | |
|---|---|---|
Cash at beginning of period | 129.18K | 344.58K |
Operating activities | ||
Net income | -67.32K | 4.40M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 0 | 230.82K |
Stock-based compensation expense | 0 | 4.57K |
| Deferred income tax benefit | 0 | 4.57K |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | 0 | 0 |
Inventories | 0 | 0 |
Accounts payable | 931.95K | 171.07K |
Cash generated by operating activities | -1.37M | -215.39K |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -479.04K |
Acquisitions Net | 0 | 0 |
Cash generated by investing activities | 342.91M | -479 |
Financing activities | ||
Common Stock Issued | 0 | 0 |
Payments for dividends | 0 | 0 |
Repurchases of common stock | -342.98M | 0 |
Repayments of term debt | 1.32M | 7.5K |
Cash used in financing activities | -341.66M | 7.5K |
Net Change In Cash | -120.35K | -215.39K |
Cash at end of period | 8.83K | 129.18K |